• News
  • Are You Eligible?
  • Careers
Specialist R&D Tax Advisors Specialist R&D Tax Advisors Specialist R&D Tax Advisors
phone-icon
phone-iconFree Call: 844-467-9267
  • Home
  • About
    • What is the R&D Tax Credit?
    • About Swanson Reed
    • Our Team
    • Our Fees
  • Services
    • R&D Eligibility Assessments
    • R&D Tax Credit Claim Preparation
    • Audit Advisory
    • Substantiation Management Consulting
    • DIY R&D Claims
    • R&D Tax Incentives Around The World
  • Knowledge Center
    • Accounting Essentials
    • Case Law
      • Legislation and Congressional Matters
      • IRS Guidance and Material
      • Treasury and Government Policy
    • Case Studies
    • Federal Grants
    • News
      • Federal
      • General
      • Energy
      • Farming
      • Life Sciences and Healthcare
      • Manufacturing
      • Public Sector
      • Technology and media communications
      • Water
    • State R&D
  • R&D Tools & Training
    • R&D Credit Calculator
    • R&D Deadline Calculator
    • Are You Eligible
    • Substantiation Tracker
    • Filing Deadlines
    • R&D Workshops
    • Live Webinars
  • Contact Us
phone-iconFree Call: 844-467-9267
  • Home
  • About
    • What is the R&D Tax Credit?
    • About Swanson Reed
    • Our Team
    • Our Fees
  • Services
    • R&D Eligibility Assessments
    • R&D Tax Credit Claim Preparation
    • Audit Advisory
    • Substantiation Management Consulting
    • DIY R&D Claims
    • R&D Tax Incentives Around The World
  • Knowledge Center
    • Accounting Essentials
    • Case Law
      • Legislation and Congressional Matters
      • IRS Guidance and Material
      • Treasury and Government Policy
    • Case Studies
    • Federal Grants
    • News
      • Federal
      • General
      • Energy
      • Farming
      • Life Sciences and Healthcare
      • Manufacturing
      • Public Sector
      • Technology and media communications
      • Water
    • State R&D
  • R&D Tools & Training
    • R&D Credit Calculator
    • R&D Deadline Calculator
    • Are You Eligible
    • Substantiation Tracker
    • Filing Deadlines
    • R&D Workshops
    • Live Webinars
  • Contact Us

Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R43/R44)

Home » Business Grants » Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R43/R44)

Development of Opioid and Adjuvant Fixed Combination Dosage Forms for the Treatment of Chronic Pain with Reduced Addiction Potential (R43/R44)  

Jurisdiction:
Federal
Incentive Type:Grant Program
Industries:
Medical
Eligible Sector:
Business
Category:
Financial Incentive
Time Period:
FY 2015
Governing Body:National Institutes of Health
What’s it worth?:Not mentioned

This is a Small Business Innovation Technology Transfer Research (STTR) grant opportunity (PA-13-387) for small business concerns (SBCs), with no more than 500 employees, to develop opioid and adjuvant single-dose treatments that enhance pain management and reduce risk of opioid addiction or other side-effects.

Maximum funding is generally $150,000 for Phase 1 of the research project and $1,000,000 for Phase 2, with the potential for 50% more (up to $225,000 in Phase 1 and $1,500,000 in Phase 2) or even higher if the additional funding is determined to be justified or necessary.  

Tweets by @SwansonReed
  • logo-1
  • logo-3
  • logo-4
  • logo-5
  • logo-22
  • logo-6
Contact Us
  • Toll Fee: 844-467-9267

    or have Swanson Reed call you.

  • ( * ) Indicates required fields

NEWS FEED

Louisiana Invention Index - December 2020

The Invention Index measures a country’s or state’s innovation output by comparing GDP growth with patent production growth.  Louisiana Invention Index December 2020: 1.55% (A- grad [...]

Kentucky Invention Index - December 2020

The Invention Index measures a country’s or state’s innovation output by comparing GDP growth with patent production growth.  Kentucky Invention Index December 2020: 1.12% (B- grade [...]

  • Privacy Policy
  • Copyright Notice ©
  • Sitemap
    • Facebook
    • Twitter
    • LinkedIn
    • Google+
    • Youtube
    Contact Us

    Send us a message and we will be in touch shortly!

    Not readable? Change text.

    Start typing and press Enter to search